Skip to content

The Effect of Probiotic Pill on Oral Mushroom in HIV-positive Patients

The Effect of Probiotic Pill on Oral Candida in HIV Positive Patients with Immunologic Failure

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170618034619N2
Enrollment
30
Registered
2017-12-11
Start date
2016-12-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Candida. B37

Interventions

Intervention 1: Intervention group: Probiotics / 10,000,000,000 colonies per ml / 2 times a day for 1 month and Anti-Retroviral Therapy. Intervention 2: Control group: Anti-Retroviral Therapy.
Treatment - Drugs
Intervention group: Probiotics / 10,000,000,000 colonies per ml / 2 times a day for 1 month and Anti-Retroviral Therapy
Control group: Anti-Retroviral Therapy

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: HIV positive People who have an Immunological Failure HIV positive People who have a Positive Salivary Candidate

Exclusion criteria

Exclusion criteria: HIV positive People with an Immunologic Failure that take Antibiotics HIV positive people with an Immunologic failure who have taken an Anti-fungal Drug HIV-positive people with an Immunologic Failure that has consumed Probiotic Products HIV positive people with an Immunologic Failure who are not Cooperatives

Design outcomes

Primary

MeasureTime frame
Candida Colony Count. Timepoint: At the Beginning of the Study (before the Intervention) and 1 Month after taking the Tablet. Method of measurement: CFU with Microbiological laboratory Methods.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTarane Farrokhnia

Islamic Azad University

t_farrokhnia@dentaliau.ac.ir+98 21 2276 3459

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026